Noviga Research Competitors and Similar CompaniesClear all

Noviga Research's competitors and similar companies include Shorla Oncology, BioNTech and OS Therapies.
Noviga Research
Noviga Research
Noviga Research is a company developing a cancer treatment medications.
Shorla Oncology
Shorla Oncology
Shorla Oncology (also known as Shorla Pharma) is a pharmaceutical company that develops cancer treatment solutions.
BioNTech
BioNTech
BioNTech is a biotechnology company developing immunotherapies for cancer and infectious diseases.
OS Therapies
OS Therapies
OS Therapies (OST) is a therapeutic company focused on identifying, developing, and commercializing treatments for osteosarcoma.
Founding Date
Founding Date
2014
Founding Date
2018
Founding Date
2008
Founding Date
2018
Type
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Södertälje, SE HQ
Locations
Clonmel, IE HQ
Cambridge, US
Locations
Mainz, DE HQ
Melbourne, AU
Wien, AT
Shanghai, CN
Paris, FR
Berlin, DE
Berlin, DE
see more
Locations
Rockville, US HQ
Employees
Employees
3
Employees
4914% increase
Employees
6,772
Employees
4
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
27.1 b
Valuation ($)
55.5 m

Financial

Net income
Net income
N/A
Net income
N/A
Net income
(€1.1b) (FY, 2025)
Net income
($28.8m) (FY, 2025)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 43.3m
Total funding raised
N/A
Total funding raised
$ 6m
For sources of this data, please see the company profile

View Company Profiles

Shorla Oncology
HQ
Clonmel, IE
Employees
49↑ 14% increase

Shorla Oncology (also known as Shorla Pharma) is a pharmaceutical company that develops cancer treatment solutions.

View company
BioNTech
HQ
Mainz, DE
Employees
6,772

BioNTech is a biotechnology company developing immunotherapies for cancer and infectious diseases.

View company
OS Therapies
HQ
Rockville, US
Employees
4

OS Therapies (OST) is a therapeutic company focused on identifying, developing, and commercializing treatments for osteosarcoma.

View company